Geron up 8 cents to close at $1.87, on about 1 million shares, three month avg is 1,191,590. Still no news or signs of a deal. Chip work your magic. If he can get $100 million for the stem cell business plus royalties, the share price should jump to $3.00. Good results on Phase 2 trials at the end of the year, $5-8 and if any can get fast tracked, which is possible, share could hit $10-12. Now, if there is no deal, share price around $1, Phase 2 results only fair or poor, share price in pennies. I feel Geron will have good results and that is only a feeling. I have 13,000+ shares on that feeling. I hope I'm right.
ACTC is slowly moving down, closed at 0.094 on 8.8 million shares, three month avg volume is 17.9 million shares. The vote on the reverse split is in May I think. With no good news we will go down to 8 cents.
Good luck in this rigged casino,
If you are interested in any of the ads please click, that's how I get paid.
No comments:
Post a Comment